UAB: Pfizer vaccine study shows promise for younger children

Jnj Vaccine00000000

vaccine covid-19

By WVUA 23 Digital Reporter Kyrsten Eller

The University of Alabama at Birmingham held a “What’s New with COVID-19” Zoom panel on Monday, including a discussion on the latest news regarding vaccinations for children.

UAB Division of Infectious Diseases Assistant Professor Dr. David Kimberlin said the Pfizer vaccine is now authorized for children ages 12 through 15, as well as those 16 years of age and above. In addition, there’s been a promising study on the effects of a smaller vaccine dose on children 5 to 11.

“The dose of the Pfizer vaccine that is being evaluated in that age group is one-third of the dose that is used for 12 and over, so it’s not simply just drawing out of a vial that is already approved by the FDA,” he said. “This is a different formulation of the vaccine, different amount of the vaccine that will be given to these younger children.”

For more updates on COVID-19 in Alabama, visit online here.

Categories: COVID-19, Local News